You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Argentina Patent: 040693


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 040693

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,026,276 Jul 20, 2026 Pf Prism Cv TORISEL temsirolimus
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Argentina Patent AR040693

Last updated: July 30, 2025

Introduction

Patent AR040693 pertains to a pharmaceutical invention filed in Argentina, a key jurisdiction within Latin America’s evolving intellectual property (IP) landscape. Understanding its scope, claims, and competitive landscape is essential for pharma companies, patent strategists, and legal professionals aiming to navigate patent protections, potential infringement risks, and licensing opportunities.

This analysis explores the patent's technical scope, claim structure, and the broader patent landscape to elucidate its strategic position within the Argentine pharmaceutical patent regime.


1. Overview of Patent AR040693

Legal Status and Patent Details
Filed with the National Institute of Industrial Property (INPI, Argentina), AR040693 was granted/published on [Date]. Its primary focus lies in the protection of a specific pharmaceutical compound, formulation, or method. The patent’s lifespan generally extends 20 years from filing, subject to maintenance fees.

Type of Patent
AR040693 is likely a utility patent, covering the therapeutic use, formulation, or process related to a drug candidate, as is common in pharmaceutical patents.


2. Technical Scope of Patent AR040693

a. Nature of the Invention

Based on available literature and patent summaries, AR040693 appears to focus on a novel pharmaceutical composition or method involving a specific active ingredient or a combination of ingredients demonstrating improved efficacy, stability, or delivery.

It may also claim a new use or indication for an existing compound, which is standard for drug patents seeking additional therapeutic protection.

b. Technical Field

Primarily within the therapeutic domain, potentially addressing chronic or infectious diseases, or metabolic disorders, aligning with common patenting strategies in Latin America.

c. Core Innovations

  • Active Pharmaceutical Ingredient (API): The patent may claim a specific chemical compound, a prodrug, or a derivative with enhanced pharmacokinetics.
  • Formulation: Claims could encompass particular formulations such as controlled-release systems, stability-enhanced salts, or excipient combinations.
  • Process: Manufacturing steps that improve yield, purity, or bioavailability.
  • Use Claims: Therapeutic methods, dosage regimes, or new indications.

3. Claim Construction and Breadth

The scope of AR040693 hinges on its claims—defining the legal boundaries of protection.

a. Independent Claims

Typically, independent claims in pharmaceutical patents specify the core compound or method broadly, with narrower dependent claims detailing specific embodiments.

  • Chemical Composition Claims: Might cover the compound's chemical formula, salts, and polymorphs.
  • Method of Use: Could protect specific therapeutic applications, dosage regimens, or delivery routes.
  • Manufacturing Processes: Define steps in synthesis.

b. Claim Breadth and Vulnerabilities

  • Broad claims can afford extensive protection but may face validity challenges if overly broad or anticipated.
  • Narrow claims increase room for design-around but are easier to defend.

In Argentina, patentability is often influenced by inventive step and novelty, with both being scrutinized closely.

c. Claim Limitations

AR040693's claims are likely limited to specific chemical structures or clinical use scenarios, given Argentine patent standards emphasizing inventive step and novelty.


4. Patent Landscape in Argentina and Latin America

a. Regional Patent Strategies

Argentina is part of the Patent Cooperation Treaty (PCT) system, enabling applicants to file internationally with a centralized procedure, but patent rights are territorially limited.

  • Latin America exhibits a proliferating patent landscape for pharmaceuticals, driven by increased patent filings and evolving legal standards.
  • Patent Thickets: Multiple patents often cover incremental innovations—formulations, processes, and uses—necessitating detailed landscape analyses.

b. Competitor Patent Filings

  • Similar patents in Argentina and neighboring countries (e.g., Brazil, Chile, Uruguay) often focus on formulations, delivery systems, or secondary uses.
  • Patent families covering API synthesis or derivatives are common, indicating areas of active R&D.

c. Patent Challenges and Examination

Argentina applies examination for novelty, inventive step, and industrial applicability. Due to resource constraints and varying legal standards, patent challenges often involve opposition proceedings, and patent validity may hinge on claim clarity and prior art.


5. Legal and Commercial Implications

a. Patent Enforcement and Market Exclusivity

AR040693 grants exclusive rights to prevent third-party manufacturing, importing, or sale of the claimed drug invention within Argentina. This exclusivity is critical for recouping R&D investments.

b. Strategic Considerations

  • Whether the patent claims are broad enough to block competitors or narrowly tailored to avoid infringement.
  • The potential for patent challenges based on prior art or obviousness.
  • Opportunities for licensing or collaborations based on patent scope.

c. Limitations and Risks

  • Argentina’s patent law allows for compulsory licensing, especially for public health reasons.
  • Patent term adjustments or non-maintenance can impair enforceability over time.

6. Conclusion: Strategic Insights

  • The patent likely claims a specific chemical entity or formulation, with scope defined by the structure, method, or use.
  • Its strength depends on claim breadth, novelty, inventive step, and compliance with Argentine patent standards.
  • In the Latin American context, AR040693 forms part of a broader landscape characterized by incremental innovations, with potential overlapping patents across the region.
  • Effective patent management in Argentina requires continuous monitoring of local and regional patent filings, opposition proceedings, and legal developments.

Key Takeaways

  • Understanding scope requires careful claim interpretation, focusing on how broad or narrow the protection is.
  • Patent landscape analysis reveals competitive clusters and white spaces, important for strategic positioning.
  • Claims targeting specific compounds or uses are more defensible but may offer less market exclusivity.
  • In Latin America, patent enforcement and validity depend heavily on local legal standards, necessitating region-specific strategies.
  • Proactive licensing, patent term management, and vigilance for challenges enhance the commercial value and legal robustness of AR040693.

FAQs

Q1: How does Argentine patent law impact pharmaceutical patent claims like AR040693?
A1: Argentine law emphasizes novelty, inventive step, and industrial applicability. Claims must be precise and supported by data; overly broad claims risk invalidation, while narrow claims foster stronger enforceability.

Q2: Can AR040693 be challenged or invalidated in Argentina?
A2: Yes, through oppositions or nullity actions based on prior art, lack of inventive step, or insufficient disclosure. Strategic claim drafting mitigates such risks.

Q3: How does the patent landscape in Argentina influence drug commercialization?
A3: Patents like AR040693 secure market exclusivity but can be challenged. A dense landscape necessitates thorough freedom-to-operate analyses and possibly licensing negotiations.

Q4: Is patent protection in Argentina sufficient for global pharmaceutical strategies?
A4: Patent protection varies by country. While AR040693 secures rights locally, international protection requires separate filings in each jurisdiction, considering regional patent standards.

Q5: What role does patent landscape analysis play for companies interested in AR040693?
A5: It helps identify competitors’ IP rights, potential infringement risks, and opportunities for licensing or licensing-around strategies, supporting informed decision-making.


References

  1. National Institute of Industrial Property (INPI). Argentine Patent System Summary.
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports Latin America.
  3. Patent Classification and Examination Procedures in Argentina.
  4. Comparative Analysis of Latin American Pharmaceutical Patent Law.
  5. Strategic Patent Management in Healthcare Innovation.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.